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We describe the reproduction of the full pattern of expression of the muscle-specific desmin gene in transgenic mice using
a 240-kb genomic clone spanning the human desmin locus. Analysis of RNA from adult tissues demonstrated that this
fragment possesses all the necessary genetic regulatory elements required to provide reproducible, site-of-integration-
independent, physiological levels of tissue-specific expression that is directly proportional to transgene copy number in all
muscle cell types. In situ hybridization revealed that in marked contrast to murine desmin which is strongly expressed in
the myotome of the somites, skeletal muscles, the heart, and smooth muscle of the vasculature by 9.5 days postcoitum,
human desmin transgene expression was completely absent from smooth muscles, was very weak and restricted to the
atrium and outflow tract within the heart, and was expressed at only 5% of murine desmin mRNA levels within the
myotome of the somites. The spatial distribution and levels of human and mouse desmin expression were not coincident
until 14.5 days postcoitum. Immunohistochemical analysis of human embryos at comparable stages of development
showed that this transgene faithfully reproduces the human and not the mouse developmental expression pattern for this
gene in transgenic mice. These results indicate that the 240-kb desmin genomic clone is capable of establishing an
independent, chromatin domain in transgenic mice and provides the first definitive data for muscle-specific locus control
region activity. In addition, our results demonstrate that the behavior of human transgenes in mice should, whenever
possible, be compared to expression patterns for that gene in human embryonic as well as adult tissues. © 1998 Academic Press
INTRODUCTION
Desmin is a muscle-specific cytoskeletal protein belong-
ing to the intermediate filament family (see Duprey and
Paulin, 1995). It is encoded by a single gene (Capetanaki et
al., 1984; Quax et al., 1985; Li et al., 1989) which has been
localized to band C3 of mouse chromosome 1 (Li et al.,
1990) and band q35 of the long arm of human chromosome
2 (Viegas-Pequignot et al., 1989). Desmin is one of the
earliest known myogenic markers to appear during devel-
opment preceding all other muscle-specific structural pro-
teins and myogenic transcription factors of the MyoD
family with the exception of myf5 (Buckingham, 1992).
Desmin appears transiently at 8.25 days postcoitum (dpc) in
the neuroectoderm, in the heart rudiment at 8.5 dpc, and at
9 dpc in the myotome (Schaart et al., 1989). Desmin is also
unique among muscle-specific proteins in that it is ex-
pressed in satellite cells (Allen et al., 1991), replicating
myoblasts (Kaufman and Foster, 1988; Li et al., 1994) and is
upregulated severalfold upon differentiation resulting in
high-level expression in all muscle cell types (cardiac,
skeletal, and smooth) both during development and postna-
tal life (Pieper et al., 1987; Kaufman and Foster, 1988; Olsen
and Capetanaki, 1989; Li and Paulin, 1991). The biology of
desmin makes it an excellent model system for the study of
muscle-specific gene expression and development. A char-
acterization of the desmin transcriptional control elements
and an elucidation of the proteins that mediate their func-
tion should provide insight into the crucial factors regulat-
ing the commitment to differentiation of all muscle cell
types.
Desmin may also play a regulatory as well as a purely
structural role during muscle development. Inhibition of
desmin expression via an antisense RNA strategy in murine
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C2C12 myoblast tissue culture cells resulted in the inhibi-
tion of fusion and myotube formation as well as a disrup-
tion in the expression of the myogenic factors MyoD and
myogenin (Li et al., 1994). Furthermore, embryoid bodies in
tissue culture derived from desmin null ES cells were
totally lacking in skeletal and smooth muscle myogenesis,
although apparently normal in cardiac muscle formation
(Weitzer et al., 1995). However, studies aimed at determin-
ing the function of desmin by the generation of null mice
show that this protein is not essential for life (Milner et al.,
1996; Li et al., 1996). Desmin null mice are viable and
fertile but possess defects in the architecture of all three
muscle types, especially cardiac tissue (Milner et al., 1996;
Li et al., 1996). The severity of damage correlates with the
extent of muscle usage. These data suggest that desmin is
primarily involved in the maintenance of muscle structure
and functional integrity.
Functional analysis in tissue culture cells of the 59
flanking region of the human (Li and Paulin, 1991) and
mouse (Li and Capetanaki, 1993, 1994) desmin genes has
revealed a common enhancer element (between nucleotides
2693 and 2973 in human and 2578 to 2976 in mouse),
which appears to be at least in part responsible for the
muscle-specific expression of these genes. This enhancer
has been found to consist of two distinct regions. The 59 end
contains a MEF-2 binding site and an E-box capable of
binding the myogenic transcription factors MyoD, myoge-
nin, MRF4, and myf5 (Li and Paulin, 1991, 1993; Li and
Capetanaki, 1993, 1994). In addition, a novel element
between the E-box and MEF-2 binding site designated Mt
(GGTATTT) and which binds a ubiquitously expressed
protein factor has recently been reported to be required for
maximal expression of human desmin in skeletal muscles
(Gao et al., 1998). The 39 half of this enhancer is a GC-rich
region with potential binding sites for Sp1 and Krox-20 (Li
and Paulin, 1991, 1993; Li and Capetanaki, 1993, 1994). The
MEF-2/E-box sites are required for the upregulation of
desmin expression in myotubes whereas the GC-rich region
appears to be responsible for transcription in myoblasts (Li
and Paulin, 1993). However, full activity of this enhancer is
dependent upon the presence of a second E-box element at
280 in the proximal promoter (Li and Capetanaki, 1993,
1994).
This 21-kb promoter- and enhancer-containing region
from both the human (Li et al., 1993) and mouse (Kuisk et
al., 1996) desmin genes has also been used to drive a
b-galactosidase (lacZ) reporter in transgenic mice. The
results show that the human element is only capable of
conferring myotomal and skeletal muscle expression (Li et
al., 1993). In addition, this transgene is completely silenced
even in skeletal muscles after 15 days postpartum (Les-
caudron et al., 1993). In contrast the lacZ gene under the
control of the murine desmin promoter region is functional
in cardiac tissue as well as in skeletal muscles during fetal
development, although no data are available regarding ex-
pression in adult tissues (Kuisk et al., 1996). However,
mutational analysis of the murine promoter has shown that
the MEF-2 binding site is essential for both somite and
cardiac expression, whereas the deletion of the E-box sup-
pressed expression only in skeletal muscle precursor cells
(Kuisk et al., 1996). Neither the human nor the murine
desmin transgenes were functional in smooth muscle. Fur-
thermore, as is usually seen with the analysis of classical
promoter and enhancer elements in transgenic mice
(Palmiter and Brinster, 1986), the levels of expression con-
ferred by both the human and murine elements were prone
to position effects, being highly variable and not related to
transgene copy number (Li et al., 1993; Kuisk et al., 1996).
It is evident from these data that the full complement of
transcriptional regulatory elements that mediate expres-
sion of the desmin gene in all muscle cell types remain to be
mapped and characterized. As a first major step towards
defining these regulatory regions, we have generated trans-
genic mice harboring a 240-kb genomic clone spanning the
human desmin locus. These mice show a reproducible,
physiological level of human desmin gene expression in all
muscle tissue types in adult animals. Interestingly, the
temporal pattern of expression of the human transgene
during fetal development was markedly delayed in cardiac
and smooth muscles relative to that of the mouse desmin
gene and was found to mirror that seen in human embryo
sections at comparable stages of development.
MATERIALS AND METHODS
Isolation of Genomic PAC Clones of the Human
Desmin Locus
A human genomic DNA library in the P1-derived, artificial
chromosome vector pCYPAC-2 (Ioannou et al., 1994) was screened
by polymerase chain reaction (PCR) amplification for the human
desmin gene. Oligonucleotides derived from the 59 region (Fig. 1B,
primer pair “a”) of the known sequence (Li et al., 1989) were used:
HD1, GTC CTC CAC CTG TGT GTT TCA AGG GGC CGT; and
HD2, AAA AGA CAC AGT CTC GGC AAG CCC CAG GGC,
corresponding to nucleotides 3984–4014 and 4348–4378, respec-
tively. A single clone 31F23 (240DES) was obtained. A modified
alkaline lysis procedure (Birnboim and Doly 1979) was used to
prepare pCYPAC clone DNA.
Generation of Transgenic Mice
The 240-kb genomic DNA fragment encompassing the human
desmin gene (240DES) was liberated from the pCYPAC-2 vector by
digestion with NotI and prepared for microinjection as described by
Schedl et al. (1993) with the following modifications. Preparative
pulsed-field gel electrophoresis (PFGE) was in 1% low melting
point agarose in 0.53 TAE (20 mM Tris–acetate, pH 8, 1 mM
EDTA). PFGE running conditions were 6 V/cm, 1- to 30-s ramped
switch times, for 16 h. DNA fragments were isolated from agarose
gel slices by digestion with Gelase (Epicentre Technologies Corp.,
Madison, WI) and equilibrated in microinjection buffer (10 mM
Tris–HCl, pH 7.4, 0.1 mM EDTA, 100 mM NaCl) by drop dialysis.
Transgenic mice were generated by pronuclear injection of the
fragment (1 ng/ml) into fertilized eggs of C57Bl/6 mice. Transgenic
founder mice were identified by PCR of tail biopsy DNA prepara-
tions using the same conditions as those in the screening of the
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pCYPAC-2 library with oligonucleotide pairs HD1 1 HD2. In
addition, the transgenic status of founder animals was confirmed
by PCR using the primers HD3, 59-CCC CTG TTG TCT TGA CTG
CCA GGT CCT GTG-39; and HD4, 59-GAG CTC AGG AAG TCC
AGG CTG CAG TAA GCG-39 corresponding to nucleotides
11,489–11,519 and 11,962–11,992 respectively of the 39 end of the
human desmin gene (Fig. 1B, primer pair “b”). Transgene copy
number and integrity were determined by Southern blot analysis of
PstI-digested tail biopsy DNA derived from heterozygous animals.
The blot was transferred under alkaline conditions onto nylon
membranes (Hybond N1, Amersham, UK). DNA from nontrans-
genic littermates and 240DES pCYPAC plasmid (200 pg) diluted in
nontransgenic mouse DNA were included as negative and positive
controls. To confirm the presence of intact copies of the human
desmin gene, the blot was initially hybridized with 32P-labeled,
nick-translated probes MA32 and MA263 (Fig. 1B) which were
derived from the 59- and 39-end regions of the gene, respectively
(Fig. 2A). The murine vav gene probed with a 1-kb NcoI fragment
derived from intron I (Ogilvy et al., 1998) acted as an internal single
copy gene reference standard. The integrity of the transgenes as a
whole was assessed by reprobing the same blot (Figs. 2B and 2C)
with MA189 and MA135 derived respectively from the 59 (Fig. 1A)
and 39 (Fig. 1B) ends of 240DES. Transgenic founders were bred by
back-crossing to wild-type C57Bl/6 mice to produce fully trans-
genic F1 offspring. Southern blots were quantified by Phosphor-
Imager (Molecular Dynamics) analysis.
Cloning the 3* Untranslated Region of the Murine
Desmin Gene
The 39 untranslated region (39UTR) of the murine desmin gene
was obtained essentially as described (Frohman et al., 1988) by
39-RACE amplification of mRNA using total RNA (5 mg) from adult
limbs of C57Bl/6 mice as the starting material. Single-stranded
cDNA was synthesized using an oligo(dT) adapter (EY41: 59-GAC
TCG AGT CGA CAT CGA T17 -39). An aliquot of this reaction
mixture was then subjected to a single PCR cycle with oligonucle-
otides SRmdes 3: 59-CAA GAC CAT TGA GAC CC-39 correspond-
ing to nucleotides 1424–1440 of the mouse desmin cDNA (Acces-
sion No. L22550) and oligo-adapter EY42 (59-GAC TCG AGT CGA
CAT CGA T-39). This mixture was then PCR amplified for 35
cycles. An aliquot of this PCR reaction mixture was reamplified for
a further 35 cycles by using oligonucleotides SRmdes2 (59-GGA
TGG AGA GGT TGT CA-39), corresponding to nucleotides 1442–
1458 of the mouse desmin cDNA and oligo-adapter EY42. This
gave rise to a 0.8-kb fragment that was then cloned into the EcoRV
site of pBluescript (KS1) (Stratagene) which hybridized to oligonu-
cleotide SRmdes 1 (59-GCG AGG CTA CAC AGC AAC AAG ATG
AAG TGC TG-39) corresponding to nucleotides 1459–1490 of the
mouse desmin cDNA. Sequence analysis of this clone (designated
MA227) showed that it overlapped mouse expressed sequence tags
with Accession Nos. AA 060301 and AA 041904 corresponding to
the murine desmin 39UTR.
Transgene Expression Analysis
Total RNA was prepared from tissues of transgenic and non-
transgenic mice by selective precipitation in 3 M LiCl, 6 M urea
(Auffray and Rougeon, 1980). Human and mouse desmin mRNA
was measured by an S1-nuclease protection assay using a mixture
of single-stranded, end-labeled DNA probes (Antonoiu et al., 1993;
Cammas and Clark, 1996) corresponding to the divergent 39UTR
regions of these two genes. The probes were prepared as follows:
Oligonucleotides mD121, 59-TGT GAT ATC CGA GAG TG-39,
and HD11 325. 59-TCA ATC TCC TGC TCC CAT CAA TCT CTC
CTG CTC CCA-39 (100 ng each), were end-labeled with T4
polynucleotide kinase and [32P]ATP (3000 Ci/mmol; ICN) in a 5-ml
reaction volume. This mixture was then added directly into a PCR
amplification reaction of MA227 and MA263 (Fig. 1B) DNA,
respectively. These PCR reactions included a common biotinylated
primer pB545: 59-TGC TGC AAG GCG ATT AA-39 starting at
position 545 bp 59 of the cDNA cloning site in the pBluescript
vector. This generated probes of 291 bp for mouse desmin and 390
bp for human desmin mRNAs possessing 170 bp of nonhomologous
pBluescript sequences linked at their 59 end. The products of the
reaction were purified by centrifugation through a Sephadex G-50
(Pharmacia) spin column. Single-stranded antisense probes were
obtained after binding to, and elution from, avidin–paramagnetic
beads (Promega; Cammas and Clark, 1996) and used directly in the
S1-nuclease protection assay as previously described (Antoniou et
al., 1993) using 20 mg of total RNA from various transgenic mouse
tissues. S1-nuclease-protected products, 121 nucleotides for mouse
and 220 nucleotides for human desmin, were resolved on a 6%
polyacrylamide gel in the presence of 8 M urea as denaturant. Gels
were dried, exposed to Kodak XAR 5 X-ray film, and quantified by
PhosphorImager.
In Situ Hybridization
Embryos were collected from the mating of transgenic mice and
staged by taking noon of the day of detection of the vaginal plug as
0.5 dpc. All embryos were dissected in phosphate-buffered saline
(PBS) and either embedded in Tissue-Tek OCT (Miles Inc., Elkhart,
IN) compound and snap-frozen in isopentane which had been
cooled in liquid nitrogen or transferred to 4% paraformaldehyde in
PBS at 4°C for a minimum of 24 h. Whole-mount in situ hybrid-
ization was carried out according to Wilkinson (1992) using the
conditions of Rosen and Beddington (1993). Hybridizations were
carried out at 70°C for 16 h with digoxigenin (DIG)-labeled sense
and antisense riboprobes prepared from a partial mouse desmin
cDNA (Li et al., 1994) and the human desmin 39UTR (MA263; Fig.
1B). After high-stringency washes, embryos were incubated with an
alkaline phosphatase-coupled anti-DIG antibody (Boehringer
Mannheim) and developed with BCIP/NBT (Boehringer Mann-
heim). Labeled embryos were embedded in 20% gelatin and 50- to
100-mm sections were cut using a Vibrotome sectioning system
(General Scientific, Redhill, Surrey, UK). Hybridizations were also
performed on sections cut from fresh-frozen embryos (10–12 mm)
or paraffin wax-embedded embryos (5–6 mm). Detection was per-
formed using the anti-DIG antibody as for whole-mount speci-
mens. Sections were counterstained with 2% acetone-washed
methyl green in 100 mM sodium acetate buffer, pH 4.2, air-dried,
and mounted with DPX (BDH, UK).
Immunohistochemistry
Paraffin wax sections (5–6 mm) of mouse embryos were cut using
a rotary microtome. Human embryo sections (5–6 mm) were
obtained from the Human Embryonic Tissue Bank (Institute of
Child Health, Great Ormond Street Hospital, London, UK). After
dewaxing and rehydration, slides were incubated in 5% H2O2 for 10
min followed by treatment within a microwave in 100 mM sodium
citrate buffer, pH 6.0, for 15 min. Immunohistochemical staining
was then conducted as follows. Sections were preincubated in
blocking buffer consisting of 5% skimmed milk in Tris-buffered
physiological saline (150 mM NaCl, 100 mM Tris–HCl, pH 7.4) for
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10 min followed by 60 min with monoclonal antibodies to desmin
(Dako DE-R-11) or a-actin (Dako HHF35 ), diluted in blocking
buffer to 1/200 and 1/5000, respectively. After incubation with a
biotinylated goat anti-mouse IgG polyclonal antibody (Dako
EO433; 1/300 dilution) for 1 h followed by streptavidin–biotin
complex conjugated to horseradish peroxidase (Dako K377) for a
further 30 min, the sections were developed with diaminobenzi-
dene 3,39 tetrahydrochloride (DAB; Sigma) for 10 min and counter-
stained with Mayer’s Haemalum, dehydrated through a graded
(70–100%) series of ethanol washes, cleared in xylene, and
mounted in DPX.
RESULTS
Generation of Transgenic Mice and Transgene
Analysis
A single genomic clone at coordinates 31F23 was ob-
tained from the human P1-derived, artificial chromosome
library in the vector CYPAC-2 (Ioannou et al., 1994).
Analysis by PFGE showed that this clone harbored an insert
of 240 kb (data not shown) and was therefore designated
240DES. This genomic fragment encompassed the entire
desmin gene with approximately 220 and 10 kb of 59 and 39
flanking sequences, respectively (Figs. 1A and 1B). Fluores-
cence in situ hybridization using 240DES as a probe on
primary human fibroblasts showed the expected two foci
within interphase nuclei which was indicative of a nonchi-
meric clone (data not shown).
The 240DES fragment was liberated from the pCYPAC-2
vector by digestion at the NotI sites that flank the insert
cloning region and used to generate transgenic mice. Seven
of 62 mice obtained after pronuclear injection of the
240DES NotI (DN) fragment were transgenic. One died
prior to breeding and could not be analyzed. The remaining
6 founders were healthy and all except DN58 generated
transgenic F1 offspring. To determine transgene copy num-
ber, DNA derived from tail biopsies of heterozygous ani-
mals was digested with PstI, Southern blotted, and double
probed with an internal desmin gene fragment (Fig. 1B,
MA32; Fig. 2A, hDes) and for murine vav (Ogilvy et al.,
1998) which acted as an endogenous single copy gene
standard (mVav, Fig. 2A). This analysis revealed that lines
DN55 and DN28 contained 1 copy of 240DES, lines DN54
and DN58 possessed 4 copies, lines DN1 and DN27 har-
bored 6 and 7 copies, respectively (Fig. 2A). This blot was
further analyzed with the probe MA263 (Fig. 1B) derived
from the 39UTR of the human desmin gene. This revealed
that the estimated copy numbers obtained with the MA32
probe (Fig. 2A) reflected intact copies of the human desmin
gene (data not shown).
In order to assess transgene integrity, the same Southern
blot shown in Fig. 1A was reanalyzed with probes derived
from the 59 (MA189; Fig. 1A) and 39 (MA135; Fig. 1B) ends of
240DES. If the 240DES transgenes are completely intact,
these probes should give one band corresponding to the
transgene end-fragment extending into the mouse genome
in the case of the single copy lines and at least two bands,
end-fragment and concatamer junction fragment(s), in the
case of the multiple copy lines.
The two single-copy transgenic lines (DN55 and DN28)
failed to give a hybridization signal with the 59 end probe
(Fig. 2B, lanes 1 and 2), indicating that both of these
transgenes had suffered a deletion of this region upon
integration (Fig. 2D). The same samples analyzed with the
39 end probe, again showed no hybridizing fragment in the
case of DN55 (Fig. 2C, lane 1) and a single band of 3.5 kb in
the case of DN28 (Fig. 2C, lane 2). These results demon-
strate that the transgene in DN55 has also suffered a
deletion at its 39 end, whereas in the case of DN28 the 39
end is intact (Fig. 2D). Further analysis showed that the
deletion at the 59 end of these two transgenes was no greater
than 40 kb and that the break point of the 39 deletion in
DN55 was approximately 1 kb past the poly(A)-addition site
(data not shown).
The four-copy line DN54 showed only a single band of 6.4
kb (Fig. 2B, arrow) corresponding to a junction fragment
from a head-to-tail concatameric integration event when
analyzed with the 59 MA189 probe (Fig. 2B, lane 4). The lack
of a second signal derived from an end fragment extending
FIG. 1. Schematic representation of the 240-kb NotI genomic
clone spanning the human desmin locus (240DES) obtained from
the pCYPAC-2 library. (A) Line drawing of 240DES showing a map
of rare restriction enzyme sites and the position and orientation of
the desmin gene (solid rectangle plus arrow). Restriction enzyme
sites shown are: Nt, NotI; C, ClaI; Nr, NruI; P, PvuI; M, MluI. Note
that the NotI sites are part of the polylinker which flanks the
cloning site of the pCYPAC-2 vector. (B) Illustration of the human
desmin gene. The position of the PCR primer pairs corresponding
to regions at the 59 (a) and 39 (b) ends of the gene which were used
to screen the pCYPAC-2 genomic library and transgenic mice are
indicated. Desmin gene exons are indicated as solid rectangles; pA,
polyadenylation site. PstI restriction enzyme sites at the 59 end of
the gene are indicated which were exploited in combination with
probe MA32 to assess transgene copy number (see Fig. 2A). The
position of the probes (hashed rectangles) used in Southern blot
analysis to assess the copy number and integrity of the 240DES
transgenes (see Figs. 2A, 2B, and 2C), are also marked. MA189 is a
1-kb HindIII–BglII fragment derived from the extreme 59 end of
240DES. MA135 is a 1.9-kb HindIII–NotI fragment obtained from a
region 10-kb 39 of the desmin gene. MA32 is a 1.3-kb SacI–KpnI
fragment extending from 2976 to 22278 bp 59 of the transcrip-
tional start site. MA263 is a 617-bp fragment derived by PCR of the
39 untranslated region of the desmin gene. Note: MA263 was also
used for analysis of human desmin transgene expression by an
S1-nuclease protection assay (Fig. 3) and in situ hybridization (Figs.
4 and 5).
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into the mouse genome indicates that this region has been
deleted from the most 59 copy in a transgene tandem array.
Analysis with the 39 MA135 probe gave two bands (Fig. 2C,
lane 4); a 6.4-kb head-to-tail concatameric junction frag-
ment (Fig. 2C, arrow) as observed with the 59 end probe and
an end fragment of 4.1 kb. PhosphorImager analysis re-
vealed that the intensity of the junction fragment was three
times greater than the end fragment (data not shown). This
confirms that the transgene copy number of DN54 is four,
organized as a tandem array, and that the 39 end is intact in
all cases (Fig. 2D).
Line DN58 which also harbors four copies of 240DES (Fig.
2A, lane 3), showed only the 6.4-kb junction fragment from
a head-to-tail concatameric integration event (Figs. 2B and
2C, arrow) when analyzed with either the 59 MA189 (Fig.
2B, lane 3) or the 39 MA135 (Fig. 2C, lane 3) probes. This
indicates a tandem array of four transgene copies with a
deletion at both the 59 and 39 ends (Fig. 2D).
The lines DN1 and DN27 which gave an estimated copy
number of 6 and 7 respectively by internal gene probing
(Fig. 2A, lanes 5 and 6) showed multiple bands (including
the 6.4-kb head-to-tail concatameric fragment), with both
FIG. 2. Determination of transgene copy number and integrity in mice generated with 240DES. (A) Tail biopsy DNA (10-mg) samples from
heterozygous transgenic animals were digested with PstI, Southern blotted, and probed simultaneously for the 240DES transgene (hDes)
using MA32 (Fig. 1B) and for the murine vav (mVav) as a single copy gene reference standard (see Materials and Methods). As expected a
2-kb band was obtained from the 59 end of the human desmin transgene (hDes; see Fig. 1B) and a 1.4-kb fragment for the murine vav (mVav)
reference gene. The blot was quantified by PhosphorImager. Transgenic mouse line numbers and transgene copy number are indicated
below each lane. DNA from nontransgenic littermates and 240DES pCYPAC plasmid (200 pg) diluted in nontransgenic mouse DNA were
included as negative (nt) and positive (c) controls. (B) The same Southern blot shown in A was reprobed with MA189 (Fig. 1A) derived from
the 59 end of 240DES. The arrow marks the position of the 6.4-kb junction fragment obtained from a head-to-tail concatameric integration
event. (C) As A but probed with MA135 (Fig. 1B) derived from the 39 end of 240DES. As in B, the arrow marks the position of the 6.4-kb
junction fragment obtained from a head-to-tail concatameric integration event. (D) Illustration summarizing transgene organization and
integrity of the single-copy (DN55 and DN28) and four-copy (DN58 and DN54) lines. The position of the human desmin gene is shown as
an open rectangle within 240DES (solid line). The presence of a deletion at either the 59 or 39 end of a given transgene copy is indicated by
a forward slash.
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the 59 (Fig. 2B, lanes 5 and 6) and 39 (Fig. 2C, lanes 5 and 6)
end probes. This indicated a complex integration pattern
with varying extents of 59 and 39 end deletions on some of
the copies.
Transgene Expression in Adult Tissues
Human desmin transgene expression was determined by
an S1-nuclease protection assay using total RNA from
tissues derived from adult heterozygous mice of 2–6
months of age. The efficiency of transgene expression was
determined by reference to the amount of endogenous
murine desmin mRNA. This was achieved by simulta-
neously hybridizing RNA samples for human and mouse
desmin mRNAs using probes derived from the divergent
39UTR where the two cDNAs show low sequence homol-
ogy. Figure 3 shows a representative analysis of three
independent experiments conducted with different litter-
mates in all cases except the founder mouse DN55 from
which we were unable to establish a line. All transgenic
mice expressed human desmin in all three types of muscle:
skeletal (leg, body wall), cardiac (heart), and smooth (uterus)
(Fig. 3). Desmin mRNA was undetectable in any of the
nonmuscle tissues (liver, kidney, spleen) that were analyzed
FIG. 3. Analysis of human 240DES transgene expression by a quantitative S1-nuclease protection assay in adult mouse tissues. Total RNA
(20 mg) from different types of adult muscle was hybridized with 10 ng each of single-stranded, end-labeled DNA probes derived from the
39 untranslated regions of the human and mouse desmin cDNAs. The figure shows the autoradiogram of the S1-nuclease protected products
after resolution on a 6% polyacrylamide gel (see Materials and Methods). The human probe yields an S1-nuclease-protected product of 220
nucleotides (hDes); the murine probe gives a protected fragment of 121 nucleotides (mDes). DN55, DN28, DN58, DN54, DN1, and DN27
refer to the 240DES transgenic mouse lines described in Fig. 2. Transgene copy number is indicated in parentheses. NT, nontransgenic
mouse samples; Hdes/mDes, expression ratios of human to mouse desmin RNA. Percentage expression per copy: derived by dividing the
total human desmin expression by the transgene copy number and expressing this as a percentage of the haploid murine expression. *, in
these samples, there was no detectable murine desmin signal which therefore did not allow quantification of human transgene expression.
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(data not shown). Expression was also detected in the lung
(see, for example, Fig. 3, lanes 20 and 25) which is due to the
relatively high (10%) smooth muscle content of this tissue.
The levels of human desmin gene expression were physio-
logical; that is, each copy of the human transgene expressed
at levels similar to those of one murine desmin allele (Fig.
3, right panel). Human desmin expression was also propor-
tional to transgene copy number because the two four-copy
lines (DN54 and DN58) gave mRNA levels approximately
four times that of the two single-copy lines (DN55 and
DN28). Furthermore, the single-copy transgenic lines
(DN55 and DN28) gave very similar expression levels.
Consistent but higher than physiological expression per
transgene copy was observed in the heart and smooth
FIG. 4. Whole-mount in situ hybridisation of DN28 (see Figs. 2 and
3) transgenic heterozygous embryos showing human and mouse
desmin expression. (A) 8.5 dpc littermates hybridized with antisense
mouse (mDes; left-hand embryo) and human (hDes; right-hand em-
bryo) desmin riboprobes. Signal is detected in the developing heart
with the mDes only. (B) 9.5 dpc embryos hybridized as in A. Staining
is observed with mDes in the somites, heart, and the paired aorta and
tail bed vasculature. Expression of hDes is detected in the somites,
although the intensity is weaker than for mDes. Smooth muscle
expression of hDes is not detected and cardiac expression is very
weak. (C, D) Enlarged left- and right-hand profile of the cardiac region
of the hDes hybridized embryo in B. Expression of hDes is confined to
the outflow tract (ot) and the developing atrium (a) but is absent from
the ventricle (v). (E) 10.5 dpc embryos hybridized as in A and B. Strong
somitic expression for both mDes and hDes is seen. Cardiac hDes
expression is not detected (right-hand embryo, arrowhead). Scale bar:
A, 250 mm; B, 1000 mm; C and D, 100 mm; E, 750 mm.
FIG. 5. Expression of human desmin in transverse sections of trans-
genic embryos. Human desmin (hDes) expression (A–D) was assessed
by in situ hybridization as described in Fig. 2. (A) Sagittal, Vibrotome
section derived from the 10.5 dpc DN28 whole-mount stained embryo
shown in Fig. 4 E. Staining for hDes is detected in the outflow tract,
atrium (a), and somites (s). Ventricular (v) expression is not detected.
(B) Section derived from a cryopreserved, 11.5 dpc DN1 (see Figs. 2 and
3) transgenic embryo. Ventricular (v) staining for hDes is first detected
at this stage, in addition to that in the atrium (a), somites (s), and the
skeletal component of the developing tongue in the mandibular (m)
region. (C) Section derived from a cryopreserved, 12.5 dpc DN1
embryo. In addition to the tissues observed at 11.5 dpc, expression is
detected in the smooth muscle of the trachea (t). (D, E) Sections
derived from a paraffin wax-embedded, 14.5 dpc DN1 embryo hybrid-
ized for hDes (D) or immunostained for combined mouse and human
desmin protein with an anti-desmin antibody (brown stained regions).
Note the colocalization of human desmin mRNA and endogenous
and transgenic desmin protein in all tissues. Expression is detected in
all skeletal, cardiac, and smooth muscle tissues and is absent from
nonmuscle tissues. The irregular staining of the somites in B and C is
due to a combination of morphological distortion resulting from the
sectioning of cryopreserved embryos, and the unusual angle of the
sections which was conducted to maximize information from the
cardiac region. Despite this distorted morphology, there is no loss of
desmin staining signal; i.e., all somites that are present in the section
are detected. This was confirmed by hybridizing for murine desmin on
adjacent sections, which showed the same staining pattern (data not
shown). Scale bar: A, 500 mm; B–E, 1000 mm.
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muscles of most lines. In addition, the exceptionally high
uterine smooth muscle expression in line DN55 (Fig. 3, lane
4), may be due to a positive position effect. These data
imply that the 240DES transgene can fully function in a
manner that is independent of its site of integration within
the mouse genome.
We also checked for the possibility that the murine
desmin may be downregulated in response to high levels of
human desmin expression. This was carried out by simul-
taneously probing skeletal and cardiac muscle tissue RNA
samples from both transgenic and nontransgenic animals
for the murine desmin and muscle creatine kinase (MCK).
The results showed that the murine desmin to MCK ratio
was the same in transgenic and nontransgenic control mice
(data not shown). This demonstrates that the high-level
expression of the human transgene did not suppress the
function of the endogenous murine desmin gene. Therefore,
the ratios of human and mouse desmin gene expression that
were observed (Fig. 3) are indicative of full physiological
function.
Developmental Regulation of Human Desmin
in Transgenic Mice
In order to determine the temporal and spatial distribu-
tion of human desmin transgene expression during devel-
opment, heterozygous transgenic embryos from lines
DN55, DN28, DN54, and DN1 were hybridized to a
human-specific desmin riboprobe. A comparison between
human and mouse expression profiles was obtained by hy-
bridizing embryonic littermates with the human-specific
39UTR (hDes) probe (see Fig. 3) and a murine cDNA probe
(mDes; Li et al., 1994). At each stage of development, 20–30
embryos from the different lines were tested. No hybridiza-
tion was observed when either probe was used in a sense
orientation (data not shown).
The results of whole-mount in situ hybridization analysis
of heterozygous transgenic embryos of line DN28 and
which are representative of all transgenic lines that were
investigated are shown in Fig. 4. As expected, embryos at
8.5 dpc gave a strong hybridization signal for mDes in the
heart (Fig. 4A, left-hand embryo; Schaart et al., 1989). In
marked contrast, no expression was detected with the hDes
probe (Fig. 4A, right-hand embryo). Expression of hDes was
first detected at 9.5 dpc in the 14 most anterior somites (Fig.
4B, right-hand embryo). The hDes expression was consis-
tently lower than for the staged-matched littermate hybrid-
ized with the mDes probe (Fig. 4B, left-hand embryo)
despite both probes being of similar length and efficiency of
DIG-labeling. In addition, to obtain a sufficiently intense
level of staining for analysis, the hDes-hybridized embryos
required developing for 4 h longer than for mDes. The more
rostral somites expressed at a higher level of both hDes and
mDes than the caudal somites, consistent with the rostro-
caudal gradient of somite maturation and were restricted to
the myotome (data not shown). Cardiac expression of hDes
at 9.5 dpc was very weak when compared to the murine
level (Fig. 4B, compare left- and right-hand embryos) and
confined to the outflow tract (ot) and the developing atrium
(a) but was excluded from the ventricle (v) (Figs. 4C and 4D).
Although at 9.5 dpc mDes expression was very pronounced
in the smooth muscle of the dorsal aorta and tail vascular
bed (Fig. 4B, left-hand embryo), there was no detectable
staining for hDes at this stage (Fig. 4B, right-hand embryo).
The difference in mouse and human desmin expression
observed by in situ hybridization was quantified by an
S1-nuclease protection assay as described for the adult
tissue samples (Fig. 3). Total RNA was extracted from
dissected 9.5 dpc DN55 homozygous embryos to give
samples which are representative of smooth, somitic/
skeletal, and cardiac muscle tissue. PhosphorImager analy-
sis showed that hDes was expressed at only 5% of that seen
for mDes in the skeletal (somitic) region (data not shown).
As expected hDes was undetectable in the cardiac- and
smooth muscle-containing samples (data not shown).
At 10.5 dpc, hDes expression remained at a lower level
than the murine gene in the somites and skeletal muscles
with little detectable staining in cardiac tissue (Fig. 4E,
arrowhead). Further analysis at 10.5 dpc by the sectioning of
the whole-mount stained embryos (Fig. 4E) revealed some
hDes expression in the atrium (Fig. 5A, a) but which was
still excluded from the ventricles (Fig. 5A, v).
Analysis of sectioned embryos revealed that expression of
hDes was first detectable in the ventricles (Fig. 5B, v) as
well as in the skeletal muscle of the developing tongue in
the mandibular region (Fig. 5B, m) at 11.5 dpc. Smooth
muscle expression of hDes was first detected in the tracheal
smooth muscle at 12.5 dpc (Fig. 5C, t). At 14.5 dpc, hDes
mRNA (Fig. 5D) was detected in all organs containing
smooth, cardiac, and skeletal muscle cells where desmin
immunostaining was also detected (Fig. 5E). Furthermore,
at 14.5 dpc mDes and hDes expression colocalized com-
pletely in all muscle cell types (data not shown).
Desmin Expression in Human Embryos
The delayed onset of hDes expression relative to mDes in
transgenic embryos could be due to at least two different
reasons. First, the 240DES transgene may be missing crucial
transcriptional control element(s) which allow desmin ex-
pression specifically at early stages of development. Alter-
natively, the hDes expression pattern may reflect a true
species difference between mice and humans. To distin-
guish between these two possibilities, an immunohisto-
chemical analysis of human embryos was conducted. The
antibodies used were DE-R-11 (aDes) which detects both
mouse and human desmin (data not shown) and HHF (aAct)
that cross-reacts equally with cardiac, skeletal, and smooth
muscle actins in mouse and human tissues (data not
shown). The aAct staining pattern therefore highlights the
position of all muscles within the sample and acts as a
general reference for the presence of these tissues.
At 30 days of gestation which is equivalent to 10.5 dpc of
the mouse, desmin was detected in the myotomal compart-
ment of the somites but was absent from the developing
heart or the smooth muscle of the vasculature (data not
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shown). At 35 day of gestation (equivalent to murine 11.5
dpc), desmin was detected in all three types of muscle cells
(Figs. 6A–6D), although the intensity and distribution was
not equivalent to the aAct staining (Figs. 6E–6H) as was
found to be the case in the mouse (data not shown). In the
skeletal muscles, desmin was most prominent in the ep-
axial muscles (Fig. 6B, arrow). Very few aDes-positive cells
were detected in the limb bud (Fig. 6A). Desmin smooth
muscle expression was first detected at this stage. The two
major bronchi showed weak desmin staining in the ventral
half (Fig. 6C, arrow) as can be seen for actin (Fig. 6G, b).
However, unlike actin (Fig. 6G, da/e), desmin was absent
from the esophagus and the dorsal aorta (Fig. 6C, da/e).
Desmin cardiac expression was restricted to the atrial
regions and there was diffuse, patchy expression in the
ventricles (Fig. 6D). The strongest aDes signal was detected
in the interventriculum septum in the area adjacent to the
lumen of the trabeculated ventricle where the Purkinje
cells of the cardiac conductance system are located (Fig. 6D,
arrow). Unfortunately, the human sections that were avail-
able did not allow the identification of the outflow tract. It
was therefore not possible to compare the staining of this
region with human desmin transgene expression (Figs. 4C
and 4D). Desmin expression differed markedly from actin
expression, which was strongly expressed in all cardiac
muscle cell types (Figs. 6E and 6H).
At 52 days of gestation (equivalent to murine 13.5 dpc),
desmin expression was detected more widely in the
muscles of the embryo (Fig. 7). Skeletal expression was
detected in the limb buds (Fig. 7A) and the developing
intercostal muscles (Fig. 7B). Cardiac expression of desmin
continued to show an uneven atrioventricular distribution
where the atria were more intensely stained than the
ventricles (Figs. 7A and 7C). Cardiac cells in the trabeculae
were stained more strongly than those in the peripheral
ventricular myocardium (Fig. 7A). As was the case at 35
days of gestation (Fig. 6A), the most intense staining was in
the cells of the conductance system located on either side
of the interventriculum septum (Fig. 7C, arrow). There was
no desmin expression detected in either the mitral (Fig. 7C,
mv) or tricuspid (Fig. 7C, tv) valves, reflecting their non-
muscle origin. The presence of desmin in smooth muscle
was detected in the circular muscle layer of the muscularis
propria of the esophagus and the ring of mesenchymal cells
immediately beneath the pulmonary epithelium in the
bronchi (Figs. 7A and 7D, arrows). Desmin was absent from
the smooth muscle layer of the aorta or vasculature of the
heart (Fig. 7A) which was nevertheless strongly positive for
muscle actin (data not shown).
DISCUSSION
240DES Establishes a Fully Functional Chromatin
Domain in Transgenic Mice
The data presented in this report demonstrate for the first
time the full pattern of desmin gene expression in trans-
genic mice. Previous work involving the human desmin
gene focused on the immediate 1-kb 59 flanking region
which encompasses muscle-specific promoter and enhancer
elements (Li and Paulin, 1991, 1993). The results showed
that this promoter/enhancer combination is only capable of
conferring myotomal and skeletal muscle expression of a
lacZ reporter gene in transgenic mice (Li et al., 1993). In
addition, this transgene is completely silenced even in
skeletal muscles after 15 days postpartum (Lescaudron et
al., 1993). In contrast, the 240DES transgene gives rise to
human desmin gene expression in all muscle cell types
(skeletal, cardiac, and smooth) in adult animals (Fig. 3).
Furthermore, 240DES reproducibly expresses at full physi-
ological levels that are directly proportional to transgene
copy number; that is, each copy of 240DES expresses at an
equivalent level to that observed for a single endogenous
murine desmin gene (Fig. 3). Importantly, this includes the
two single-copy lines DN28 and DN55.
This pattern of site-of-integration-independent expres-
sion indicates that 240DES not only possesses all the
necessary genetic control to provide desmin gene expres-
sion in all muscle cell types, but also includes LCR-type
regulatory elements that are required to open silent chro-
matin and to establish and maintain a muscle-specific
domain (see Felsenfeld, 1992; Dillon and Grosveld, 1994).
LCRs are tissue-specific transcriptional regulatory ele-
ments that are defined by their ability to negate chromatin
position effects in transgenic mice (Grosveld et al., 1987;
Greaves et. al., 1989; Bonifer et al., 1990; Carson and Wiles,
1993; Diaz et al., 1994; Montoliu, et al., 1996) especially as
single-copy transgenes (Ellis et al., 1996 and 1997), and
which are capable of preventing the spread of heterochro-
matin (Festenstein et al., 1996; Milot et al., 1996).
FIG. 6. Immunohistochemical analysis of desmin and muscle a-actin expression in 35-day-old human embryo sections. Transverse
sections of human embryo 19/65 and 19/66 (Human Embryonic Tissue Bank, Institute of Child Health, Great Ormond Street Hospital,
London), were immunolabeled with antibodies against desmin (A–D) and muscle a-actin (E–H). A, E: low-power (32.5) original
magnifications. (B) Magnification of A showing desmin epaxial muscle expression (arrow). (C) Magnification of A showing smooth muscle
desmin expression in the ventral half of the bronchi (arrow) but is absent from the esophagus (e) and dorsal aorta (da). (D) Magnification of
A showing that desmin is expressed in the left atrium (la), faintly in the left ventricle (lv), and more strongly in the Purkinje cells of the
cardiac conductance (arrow) located at either side of the interventriculum septum (is). (E) muscle a-actin staining showing expression in all
muscle cells in the embryo. (F) Magnification of E showing a more extensive epaxial muscle staining (arrow) than that seen for desmin (B).
(G) magnification of E showing extensive muscle a-actin staining in the bronchi (b), esophagus (e), and dorsal aorta (da). (H) Magnification
of E showing muscle a-actin staining in all cardiomyocytes. Scale bar: A and E, 200 mm; B–D and F–H, 50 mm.
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Previous reports on the analysis of other highly expressed
muscle specific genes such as skeletal (Brennan and Harde-
man, 1993) or cardiac (Dunwoodie et al., 1994) actin show a
variable level of expression which is not related to trans-
gene copy number. The 59-flanking region of the murine b
myosin heavy chain (Knotts et al., 1995) and the muscle
promoter of the human (Salminen et al., 1994) and rat
(Hashido et al., 1995) aldolase A gene have also been
reported to confer muscle-specific, transgene copy number-
dependent expression in mice. However, in contrast to
240DES these transgenes do not appear to possess a true,
physiological chromatin opening capability, since they nei-
ther produce full levels of gene expression nor do they
function at single or low transgene copy number, suggesting
the lack of complete LCR activity. The expression pattern
displayed by 240DES therefore constitutes the first defini-
tive evidence for muscle-specific LCR activity. It is now
well established that LCRs are intimately involved in
regulating the developmental pattern of gene expression as
well as establishing an open chromatin domain (Strouboulis
et al., 1992; Fraser et al., 1993; Wijgerde et al., 1995). Our
data suggest that a similar mechanism is in operation to
regulate desmin gene expression throughout fetal and adult
life.
The combined data from the two single copy transgenic
lines suggests that the elements responsible for full physi-
ological levels of desmin gene expression are not located 3’
of the poly(A)-addition site. This is due to the fact that
despite a deletion of virtually all 3’ flanking sequences in
line DN55 (Fig. 2C, lane 1) and 40 kb at the 59 end of
240DES in both lines DN28 (Fig. 2B, lane 2) and DN55 (Fig.
2B, lane 1), these transgenes were fully functional (Fig. 3,
lanes 1-10). Our results therefore constitute a major first
step towards defining the regulatory elements, including
LCR, which are responsible for conferring desmin gene
expression at physiological levels in all muscle cell types.
Expression Pattern of 240DES during Mouse
Development
Neuroectodermal expression. Murine desmin is first
detected in the mouse embryo by immunofluorescence
microscopy in the neuroectoderm at 8.25 dpc where it is
transiently coexpressed with vimentin and keratin (Babai et
al., 1990; Hill et al., 1986; Mayo et al., 1992; Schaart et al.,
1989). Murine (Kuisk et al., 1996) and human (Li et al.,
1993) desmin promoter studies have demonstrated specific
expression of a linked lacZ reporter gene in the neuroepi-
thelium from 8.25 dpc which continues until 13.5 dpc. We
were unable to detect any expression of either human or
murine desmin by in situ hybridization in the neuroecto-
derm at any stage of development (data not shown). Our
observations confirm previous reports which also showed
an inability to detect desmin at the level of mRNA at this
stage of development (Li et al., 1993). This finding may be
due to a combination of low and transient mRNA expres-
sion in the neuroepithelium at 8.25 dpc and perhaps to the
shorter half-life of desmin mRNA compared to that for
desmin or lacZ protein detection used in other studies.
Furthermore, the continual presence of b-galactosidase ac-
tivity may reflect the observation that both human and
mouse desmin promoter-driven lacZ transgene expression
in the neuroectoderm persisted beyond the time when the
endogenous murine desmin gene had switched off (Kuisk et
al., 1996; Li et al., 1993).
Somitic and skeletal muscle expression. Expression of
the 240DES transgene was first detected in the myotome of
the somites at 9.5 dpc (Fig. 4B), albeit at only 5% of the level
seen for the endogenous murine desmin gene (data not
shown). This reduced level of expression was also evident in
human embryo sections at a comparable (30-day-old) devel-
opmental stage, where desmin expression was observed in
the somites but only in a subset of the cells that were
positive for muscle actin (data not shown). This difference
in the staining pattern between the desmin and muscle
actin antibodies in human sections was not observed in
equivalent staged murine embryos (data not shown). The
difference in murine and 240DES transgene expression only
persists during early embryogenesis since, by 14.5 dpc,
hDes and mDes coexpressed at equal levels (data not
shown). This mirrored the situation in equivalent 52-day-
old human embryos where aAct and aDes antibodies gave
the same overlapping staining pattern in skeletal muscle
cells (data not shown).
Cardiac expression. Murine desmin is first detected in
the heart rudiment by immunostaining at 8.5 dpc (Fig. 4A,
left-hand embryo; Babai et al., 1990; Hill et al., 1986; Mayo
et al., 1992; Schaart et al., 1989). Subsequently, mDes is
expressed in all cardiomyocytes throughout development
and postnatal life. The 21-kb promoter region from the
murine desmin gene used to drive a lacZ reporter has been
shown to provide sufficient regulatory regions to direct
FIG. 7. Immunohistochemical analysis of desmin expression in a 52-day-old human embryo section. A transverse section of human
embryo 147/35 (Human Embryonic Tissue Bank, Institute of Child Health, Great Ormond Street Hospital, London) was immunolabeled
with an a-desmin antibody. (A) Low-power (31) original magnification showing staining in the skeletal muscles of the limbs and intercostal
muscles, smooth muscles of the esophagus and lung and myocytes in the atria and ventricles. (B) Magnification of A showing skeletal
muscle expression in developing intercostal muscles. (C) Magnification of the heart region of A showing intense staining in the cardiac
conductance (arrow) and right atrium (ra) but lower intensity in the interventricular septum (is). The mitral (mv) and tricuspid (tv) valves
are unstained. (D) magnification of A showing desmin staining in the smooth muscle layers of the esophagus (small arrow) and bronchiole
(large arrow). Scale bar: A, 100 mm; B and D, 10 mm; C, 50 mm.
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expression in the cardiac tube at 8.0 dpc. in transgenic mice
(Kuisk et al., 1996). However, at later developmental time
points, the expression was restricted to the ventricular
regions of the heart and not observed in the atria. Addition-
ally, there were differences in the levels of expression in the
right and left ventricles. In contrast, the equivalent region
from the human desmin gene used with the same reporter
gene assay failed to express in cardiac muscle at any stage of
development (Li et al., 1993).
Expression of 240DES in transgenic mice was also absent
from the heart during early cardiogenesis (Fig. 4A, right-
hand embryo). However, low levels of hDes expression were
detected at 9.5 dpc (Fig. 4B, right-hand embryo) but which
were confined to the outflow tract and the developing
atrium (Figs. 4C and 4D). Staining of hDes was excluded
from the ventricles until 11.5 dpc (Fig. 5B, v), when hDes
transgene and endogenous mDes expression fully colocalize
in the heart (data not shown).
Analysis of human embryos at 30 days of gestation
(equivalent to 10.5 dpc in the mouse) showed that human
desmin protein was undetectable in the heart by immuno-
staining (data not shown). At 35 days of gestation (equiva-
lent to 11.5 dpc in the mouse) hDes immunostaining in the
heart showed clear differences between the atria and ven-
tricles (Figs. 6A and 6D). We did not observe differences in
the intensity of immunostaining in the left and right
ventricle as was reported for the murine desmin promoter–
lacZ reporter transgene study (Kuisk et al., 1996). There-
fore, cardiac expression of desmin in human embryos
clearly starts later in development than mouse desmin. The
240DES transgene would thus appear to be reproducing the
delayed human pattern of cardiac desmin expression in
transgenic mice.
However, it is also apparent that there is a discrepancy in
the onset of cardiac expression of 240DES in transgenic
mice and the detection of desmin in human embryos. The
lack of desmin protein in 30-day-old human embryos (data
not shown) contrasts with the positive 240DES signal at
10.5 dpc (Fig. 5A). This inconsistency is in all likelihood
due to the fact that 240DES transgene expression was
measured by mRNA in situ hybridization, whereas analysis
of human embryos was by antibody staining against desmin
protein. It is quite possible that human desmin gene expres-
sion has commenced in the heart of 30-day-old embryos but
that desmin protein has not as yet accumulated in suffi-
cient quantities for immunohistochemical detection.
A characteristic feature of cardiac development is atrial
contractions preceding those of the ventricles such that the
maturation of function is accompanied by specialization of
the contractile protein machinery (see Lyons, 1994). Some
proteins are expressed in a chamber-specific manner, for
example, myosin light chain (MLC) 2V (O’Brien et al., 1993)
and atrial myosin heavy chain (MHC; Stainier and Fishman,
1992). Other gene products are downregulated to achieve
chamber specificity as is the case for MHC a, MHC b and
MLC 1V (Lyons, 1994). Our data show that human desmin
differs from its murine counterpart in that it appears to
belong to the group of genes whose expression is chamber-
specific at early but not at later stages of development
(Chien et al., 1993; Fishman and Chien, 1997).
Although the developmental regulation of hDes in the
240DES transgenic mice and human embryos differ from
that of murine desmin, at the adult stage hDes is expressed
at higher than physiological levels (Fig. 3), suggesting that
there may be species differences not only in the develop-
mental regulation but in the total transcriptional output
from the two systems.
Cardiac conductance system. Heart contraction is co-
ordinated by the propagation of cardiac action potentials
from the atria to the ventricles through the specialized
tissue of the cardiac conduction system (Purkinje fibers)
which displays a skeletal muscle pattern of gene expression
(Alyonycheva et al., 1997). Desmin in human embryos (Fig.
6D) and in human desmin promoter–lacZ reporter trans-
genic mouse studies (Li et al., 1993) expresses in the
conduction system in the absence of ventricular expression.
Because there are no unique markers for Purkinje fibers
available, it is not possible to determine if murine desmin is
expressed in these cells. However, since desmin expression
is not excluded from any area of the developing mouse
heart, it is a reasonable assumption that desmin expression
is also present in the conductance system but that it is not
more abundant than in the surrounding myocardial cells.
The skeletal muscle nature of the conductance system
(Alyonycheva et al., 1997) may explain why hDes is de-
tected in this tissue prior to the ventricular compartment in
the developing human heart.
Smooth muscle expression. Smooth muscle expression
of desmin is first detected in the mouse at 9.0 dpc in the
developing vasculature in the cardiac region extending to
the paired dorsal aorta and tail bed vasculature by 9.5 dpc
(Fig. 4B). Expression in the aorta appears to be transient,
decreasing in intensity such that by 14.5 dpc little or no
desmin remains (data not shown). The downregulation of
desmin in the embryonic vasculature parallels that of a-
and g- smooth muscle actin (McHugh 1995). Murine
desmin is detected in the respiratory tract within the ring of
mesenchymal cells immediately beneath the pulmonary
epithelium of the major bronchi. In addition, it is also found
in the esophagus within the circular muscle layer of the
muscularis propria at 11.5 dpc (data not shown). At 14.5 dpc
murine desmin can be detected in all smooth muscle cell
containing tissues with the exception of the vasculature
(Fig. 5E).
The murine (Li et al., 1993) and human (Kuisk et al.,
1996) desmin promoters are unable to drive expression of a
lacZ reporter gene within the smooth muscle compart-
ment. In marked contrast, the 240DES human desmin locus
is fully expressed in smooth muscle, although not in the
temporal and spatial pattern observed for the endogenous
mouse desmin gene. Expression of hDes in the smooth
muscle of the vasculature, monitored by in situ hybridiza-
tion in these transgenic mice, was not detected until 12.5
dpc and then only in the respiratory tract (Fig. 5C). This is
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72 h after murine smooth muscle desmin is first detected
(Fig. 4B). Gastrointestinal and urinogenital expression is
detected at the same time as mDes (Fig. 5D and 5E).
In human embryos, desmin is absent from smooth
muscle at 30 days of gestation (data not shown) and is
detected weakly in the pulmonary smooth muscle at 35
days (Fig. 6C), and in the esophagus there is strong staining
at 52 days of gestation (Fig. 7D). Therefore, again the
delayed expression of 240DES in the smooth muscle of
transgenic mice reflects the developmental pattern in hu-
man embryos.
It is unclear why there are differences in the timing and
distribution of desmin expression in mice and humans. The
desmin-null mice are viable and fertile, suggesting that
desmin is not essential for life (Milner et al., 1996; Li et al.,
1996). Presumably other members of the intermediate fila-
ment family of proteins can substitute for desmin during
early human embryogenesis. A likely candidate for this
function is vimentin which we found to be abundantly
expressed in all desmin-positive tissues at the embryonic
stages tested (data not shown). Generally, our data highlight
the importance of comparing, whenever possible, human
transgene expression in mice to the human condition since
major differences between the developmental expression of
genes between these two species may occur.
In summary, despite the fact that the levels of human
and mouse desmin gene expression were equivalent in all
muscle cell types in adult animals (Fig. 3), human desmin
expression from the 240DES transgene during mouse
development is markedly delayed relative to that for
murine desmin. This is especially the case within cardiac
and smooth muscle tissue. The analysis of human em-
bryo sections (Figs. 6 and 7, and data not shown) demon-
strates that the 240DES clone reproduces the human
developmental pattern of expression within a transgenic
mouse background and that it is therefore not lacking in
any crucial genetic control elements. This is similar to
the finding with the human b-globin locus analyzed in
transgenic mice which gave a human rather than a mouse
developmental pattern of expression (Strouboulis et al.,
1992). Therefore, the variance in the timing of expression
between human and mouse desmin is in all probability
due to differences in the genetic control elements of
these two genes which allows the murine gene to respond
to, and be activated by, the complement of transcription
factors present in murine muscle cells at these much
earlier stages of development.
The results obtained with the 240DES clone constitute a
major step toward defining the transcriptional control ele-
ments which allow full physiological levels of expression of
the desmin gene in all muscle cell types. Future work aimed
at mapping and characterizing the genetic elements which
are clearly present on this genomic fragment will also
provide insight into fundamental questions regarding the
spatial and temporal developmental expression pattern of
this important muscle specific gene.
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